ETFs positioned on UCB

Name YTD change Weight AuM
+8.73%-.--% 6,576 M€
+13.05%-.--% 750 M€
+11.54%-.--% 13 M€
+1.05%-.--% 51 M€
+9.27%-.--% 66 M€
+7.60%-.--% 75 M€
+13.89%-.--% 4,105 M€
+9.49%-.--% 274 M€
+13.86%-.--% 298 M€
+8.41%-.--% 6 M€
-.--%-.--% 1,683 M€
+13.60%-.--% 1,674 M€
+7.83%-.--% 1,193 M€
+14.37%13.82% 85 M€
+11.02%9% 162 M€
+16.12%4.37% 49 M€
+3.32%4.19% 94 M€
-1.51%2.41% 391 M€
+15.12%2.2% 1,260 M€
-1.53%1.85% 1,024 M€
+6.00%1.85% 9 M€
+2.32%1.79% 25 M€
-3.37%1.75% 820 M€
+8.58%1.69% 31 M€
+14.03%1.69% 31 M€
+11.87%1.49% 18 M€
+9.40%1.45% 490 M€
+9.14%1.45% 3,283 M€
+10.41%1.34% 160 M€
+5.42%1.3% 64 M€
+10.69%1.28% 173 M€
+14.10%1.19% 757 M€
+13.52%1.18% 17 M€
+9.53%1.17% 13 M€
+5.32%1.13% 22 M€
+8.27%1.13% 16 M€
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!